Eyenuk Welcomes Paul Praino as Chief Commercial Officer
February 16, 2023 08:00 ET
|
Eyenuk, Inc.
LOS ANGELES, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Eyenuk, a global artificial intelligence (AI) digital health company, and the leader in real-world applications for AI Eye Screening™ and AI Predictive...
Eyenuk Secures the First European Union MDR Certification for Autonomous AI Detection of Diabetic Retinopathy, Age-Related Macular Degeneration, and Glaucoma
January 31, 2023 07:00 ET
|
Eyenuk, Inc.
LOS ANGELES, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Eyenuk, a global artificial intelligence (AI) digital health company, and the leader in real-world applications for AI Eye Screening™ and AI Predictive...
UK National Screening Committee Report Singles Out Eyenuk’s EyeArt as the Only Diabetic Eye Screening AI Technology Ready for Live Clinical Implementation in the National Health Service
June 01, 2022 03:05 ET
|
Eyenuk, Inc.
LOS ANGELES, June 01, 2022 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...
Eyenuk Joins the Population Health Alliance, Paving Way for Autonomous AI to Improve Diabetes Complications
March 10, 2022 08:00 ET
|
Eyenuk, Inc.
WASHINGTON, March 10, 2022 (GLOBE NEWSWIRE) -- Population Health Alliance (PHA), the industry’s only multi-stakeholder professional and trade association solely focused on population health,...
Eyenuk Launches EyeArt AI System in South Africa in Collaboration with Discovery Health
December 07, 2021 10:36 ET
|
Eyenuk, Inc.
LOS ANGELES, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...
Eyenuk Announces Publication of Strong EyeArt® Pivotal Clinical Trial Results in JAMA Network Open
November 15, 2021 14:38 ET
|
Eyenuk, Inc.
LOS ANGELES, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...
Eyenuk Applauds CMS CY 2022 Medicare Physician Fee Schedule Final Rule to Establish National Price for Autonomous AI Technology
November 04, 2021 17:09 ET
|
Eyenuk, Inc.
LOS ANGELES, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...
Eyenuk AI Technology Selected for Diabetic Eye Testing in Vietnam Supported by The Fred Hollows Foundation
July 26, 2021 09:00 ET
|
Eyenuk, Inc.
LOS ANGELES, July 26, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...
Eyenuk Announces $6.2 Million Financing to Accelerate Adoption of FDA-cleared AI Technology for Detection of Diabetic Retinopathy
July 20, 2021 08:00 ET
|
Eyenuk, Inc.
LOS ANGELES, July 20, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...
Eyenuk Reports Strong 2021 Business Growth
May 12, 2021 11:00 ET
|
Eyenuk, Inc.
LOS ANGELES, May 12, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...